Skip to content

Author

Xue-Qing Ma

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Safety signals of tocilizumab in pediatric patients: A real-world pharmacovigilance analysis based on the FAERS database with network pharmacology insights

ABSTRACT Tocilizumab, a humanized monoclonal antibody targeting the interleukin-6 receptor, is widely used in immune-mediated diseases, yet its real-world safety in pediatric populations remains insufficiently characterized. This retrospective pharmacovigilance study analyzed adverse event (AE) reports from the U.S. Fo...

Gang Wu, Xue-Qing Ma, Bin Zhu et al. · 0 citations
Open access Sep 2026

Pharmacovigilance signals of dupilumab among pediatric patients: A real‑world analysis based on the FAERS database

ABSTRACT Dupilumab is effective for the treatment of moderate‑to‑severe type 2 inflammatory diseases; however, its real‑world safety profile in pediatric patients remains to be further clarified. This retrospective pharmacovigilance study analyzed U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)...

Xue-Qing Ma, Jiao-Jiao Fan, Ben Liu · 2 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.